Orion Portfolio Solutions LLC Has $3.80 Million Stake in Avantor, Inc. (NYSE:AVTR)

Orion Portfolio Solutions LLC increased its stake in shares of Avantor, Inc. (NYSE:AVTR) by 6.3% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 146,684 shares of the company’s stock after acquiring an additional 8,696 shares during the period. Orion Portfolio Solutions LLC’s holdings in Avantor were worth $3,795,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Blue Trust Inc. increased its holdings in shares of Avantor by 1,830.3% during the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after acquiring an additional 1,391 shares during the last quarter. UMB Bank n.a. acquired a new stake in Avantor in the 3rd quarter valued at approximately $49,000. Nisa Investment Advisors LLC grew its holdings in Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after buying an additional 835 shares during the last quarter. GAMMA Investing LLC grew its holdings in Avantor by 89.9% in the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after buying an additional 1,285 shares during the last quarter. Finally, ORG Partners LLC grew its holdings in Avantor by 5,773.0% in the 2nd quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock valued at $122,000 after buying an additional 5,773 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Trading Up 3.3 %

Shares of AVTR opened at $22.09 on Tuesday. The stock has a fifty day moving average price of $22.70 and a two-hundred day moving average price of $23.57. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. Avantor, Inc. has a 52-week low of $19.59 and a 52-week high of $28.00. The company has a market cap of $15.03 billion, a price-to-earnings ratio of 48.02, a PEG ratio of 2.59 and a beta of 1.29.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on AVTR. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $34.00 target price on shares of Avantor in a report on Thursday, September 26th. Barclays decreased their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, October 25th. UBS Group decreased their price objective on Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a report on Tuesday, October 8th. Robert W. Baird decreased their price objective on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Finally, Wells Fargo & Company decreased their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $27.69.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.